Frank Wille1,2, Jennifer S Breel1,2, Eric W P Bakker3, Markus W Hollmann2. 1. Department of Anesthesiology-Pain Medicine, Diakonessenhuis Zeist, Zeist, The Netherlands. 2. Department of Anesthesiology-Pain Medicine, Academic Medical Center (AMC) Amsterdam, Amsterdam, The Netherlands. 3. Division Clinical Methods and Public Health, Department of Clinical Epidemiology, Biostatistics and Bioinformatics, University of Amsterdam, Faculty of Medicine, Academic Medical Center (AMC), Amsterdam, The Netherlands.
Abstract
OBJECTIVES: To examine whether converting from conventional Spinal Cord Stimulation (SCS) to High Density (HD) SCS reduces neuropathic pain over a period of 12 months in patients with failed SCS therapy. METHODS: Retrospective, open label, single center, consecutive case series of 30 neuropathic pain patients (Failed Back Surgery Syndrome [FBSS], Complex Regional Pain Syndrome [CRPS], and polyneuropathy [NP]). Patients with an initial adequate response to conventional SCS, but in whom pain increased over time, were included (Numeric Rating Scales [NRS] >6). These patients were stimulated with HD-SCS parameters and followed-up for 12 months. We report pain intensity, measured with NRS, before SCS implantation, 1 and 3 months after starting SCS with conventional stimulation, and after 1, 6, and 12 months of HD SCS. RESULTS: Pain reduction with conventional stimulation was initially adequate (NRS mean 8.6 to 5.3 at three months postimplant) but increased over time to a mean NRS of 7.7 at the time of reprogramming. NRS scores decreased significantly to 4.3 (p = 0.015) after reprogramming from conventional SCS (30 Hz, 300 µsec, 3.0 V) to HD SCS (409 Hz, range 130-1000 Hz, 409 µsec, 2.4V) in the patients still using HD-SCS at 12 months. In the nonresponders (patients who stopped HD-SCS for any reason), 76% had a diagnosis of FBSS. Almost half of the patients aborting HD-SCS preferred to feel paresthesias despite better pain relief. There was a significant difference between nonresponders and responders regarding the amount of electrical energy delivered to the spinal cord. CONCLUSION: Neuropathic pain suppression is significantly enhanced after converting from failed conventional SCS to HD SCS in patients with FBSS, CRPS, and NP over a measured period of 12 months. There appears to be a dose-related response between the amount of energy delivered to the spinal cord and clinical effect.
OBJECTIVES: To examine whether converting from conventional Spinal Cord Stimulation (SCS) to High Density (HD) SCS reduces neuropathic pain over a period of 12 months in patients with failed SCS therapy. METHODS: Retrospective, open label, single center, consecutive case series of 30 neuropathic pain patients (Failed Back Surgery Syndrome [FBSS], Complex Regional Pain Syndrome [CRPS], and polyneuropathy [NP]). Patients with an initial adequate response to conventional SCS, but in whom pain increased over time, were included (Numeric Rating Scales [NRS] >6). These patients were stimulated with HD-SCS parameters and followed-up for 12 months. We report pain intensity, measured with NRS, before SCS implantation, 1 and 3 months after starting SCS with conventional stimulation, and after 1, 6, and 12 months of HD SCS. RESULTS: Pain reduction with conventional stimulation was initially adequate (NRS mean 8.6 to 5.3 at three months postimplant) but increased over time to a mean NRS of 7.7 at the time of reprogramming. NRS scores decreased significantly to 4.3 (p = 0.015) after reprogramming from conventional SCS (30 Hz, 300 µsec, 3.0 V) to HD SCS (409 Hz, range 130-1000 Hz, 409 µsec, 2.4V) in the patients still using HD-SCS at 12 months. In the nonresponders (patients who stopped HD-SCS for any reason), 76% had a diagnosis of FBSS. Almost half of the patients aborting HD-SCS preferred to feel paresthesias despite better pain relief. There was a significant difference between nonresponders and responders regarding the amount of electrical energy delivered to the spinal cord. CONCLUSION: Neuropathic pain suppression is significantly enhanced after converting from failed conventional SCS to HD SCS in patients with FBSS, CRPS, and NP over a measured period of 12 months. There appears to be a dose-related response between the amount of energy delivered to the spinal cord and clinical effect.
Keywords:
Charge per second; complex regional pain syndrome; failed back surgery syndrome; high density; invasive pain management; neuromodulation; pulse density
Authors: Jean-Pierre Van Buyten; Frank Wille; Iris Smet; Carin Wensing; Jennifer Breel; Edward Karst; Marieke Devos; Katja Pöggel-Krämer; Jan Vesper Journal: Neuromodulation Date: 2017-08-18
Authors: Sander De Groote; Mats De Jaeger; Peter Van Schuerbeek; Stefan Sunaert; Ronald Peeters; Dirk Loeckx; Lisa Goudman; Patrice Forget; Ann De Smedt; Maarten Moens Journal: J Pain Res Date: 2018-10-24 Impact factor: 3.133
Authors: Jan Willem Kallewaard; Jose Francisco Paz-Solis; Pasquale De Negri; Maria Angeles Canós-Verdecho; Hayat Belaid; Simon J Thomson; David Abejón; Jan Vesper; Vivek Mehta; Philippe Rigoard; Paolo Maino; Sarah Love-Jones; Isaac F Peña; Simon Bayerl; Christophe Perruchoud; Renaud Bougeard; Cleo Mertz; Yu Pei; Roshini Jain Journal: J Clin Med Date: 2021-09-10 Impact factor: 4.964
Authors: John A Hatheway; Vipul Mangal; Michael A Fishman; Philip Kim; Binit Shah; Rainer Vogel; Vincent Galan; Steven Severyn; Tristan E Weaver; David A Provenzano; Eric Chang; Michael H Verdolin; Gregory Howes; Armando Villarreal; Steven Falowski; Kelly Hendrickson; Katherine Stromberg; Lachlan Davies; Lisa Johanek; Matthew T Kelly Journal: Neuromodulation Date: 2020-12-09
Authors: Sander De Groote; Lisa Goudman; Ronald Peeters; Bengt Linderoth; Peter Van Schuerbeek; Stefan Sunaert; Mats De Jaeger; Ann De Smedt; José De Andrés; Maarten Moens Journal: Neuroimage Clin Date: 2019-11-12 Impact factor: 4.881
Authors: Richard L Witkam; Erkan Kurt; Robert van Dongen; Inge Arnts; Monique A H Steegers; Kris C P Vissers; Dylan J H A Henssen; Yvonne Engels Journal: Neuromodulation Date: 2020-09-23